02112.HK announced that the company, through its wholly owned subsidiaries Shenzhen Grace Times Life Technology Co., Ltd. And Punkang (Zhejiang) Stem Cell Technology Co., Ltd. (hereinafter referred to as: Punkang Group)The Strategic Cooperation Framework Agreement was signed on September 13, 2023, which aims to strengthen the two sides in the field of large health industries (The cooperation of the plant cambium stem cell platform technology project) to promote the business development of both sides.
Punkang Group is a holding group specializing in traditional Chinese and western medicine health therapy, medical beauty physiotherapy, traditional Chinese medicine health care, health consulting services, its companies Chongqing Kangertai Integrated traditional Chinese and Western Medicine Hospital Co., Ltd., Dexuan (Zhejiang) Health Management Co., Ltd., the group's independent research and development of cell diagnosis and treatment, traditional Chinese medicine diagnosis and treatment and health consultation system has been widely known, to provide many customers with comprehensive health management and medical services. Punkang developed online and offline intelligent health management platform "Tang XVIII" series, to chain operation, and equipped with a complete management system.Through this cooperation, the two sides are expected to have broad business. Punkang expects sales of the Punkang Group to exceed 1 billion yuan in 2024.
In the future, the two sides will give full play to each other's advantages in brand, capital, resources, technology and products, and actively explore innovative cooperative development models that are in line with the industrial development and interests of both sides. Punkang Group will first use its extensive sales network to assist Grace Biotechnology in the sales and promotion of a series of plant cambium stem cell products and technology projects.